OraSure Technologies Inc
NASDAQ:OSUR

Watchlist Manager
OraSure Technologies Inc Logo
OraSure Technologies Inc
NASDAQ:OSUR
Watchlist
Price: 3.88 USD 0.78% Market Closed
Market Cap: 289.4m USD
Have any thoughts about
OraSure Technologies Inc?
Write Note

OraSure Technologies Inc
Total Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

OraSure Technologies Inc
Total Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
OraSure Technologies Inc
NASDAQ:OSUR
Total Liabilities
$38.5m
CAGR 3-Years
-17%
CAGR 5-Years
0%
CAGR 10-Years
3%
Haemonetics Corp
NYSE:HAE
Total Liabilities
$1.6B
CAGR 3-Years
14%
CAGR 5-Years
22%
CAGR 10-Years
10%
ICU Medical Inc
NASDAQ:ICUI
Total Liabilities
$2.3B
CAGR 3-Years
108%
CAGR 5-Years
50%
CAGR 10-Years
51%
Align Technology Inc
NASDAQ:ALGN
Total Liabilities
$2.4B
CAGR 3-Years
4%
CAGR 5-Years
18%
CAGR 10-Years
27%
Lantheus Holdings Inc
NASDAQ:LNTH
Total Liabilities
$869.9m
CAGR 3-Years
36%
CAGR 5-Years
24%
CAGR 10-Years
6%
Merit Medical Systems Inc
NASDAQ:MMSI
Total Liabilities
$1.1B
CAGR 3-Years
19%
CAGR 5-Years
5%
CAGR 10-Years
13%
No Stocks Found

OraSure Technologies Inc
Glance View

Market Cap
289.4m USD
Industry
Health Care

OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. The company is headquartered in Bethlehem, Pennsylvania and currently employs 785 full-time employees. The firm's products include molecular sampling kits for the genome and microbiome services and analytics, rapid diagnostics for infectious disease, and tests for substance abuse. OraSure’s segments include Diagnostics segment and Molecular Collection Systems segment. The Diagnostics business primarily consists of the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices. The Molecular Solutions business consists of the manufacture and sale of kits that are used to collect, stabilize, transport and store biological samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, infectious disease diagnostics, pharmacogenomics, personalized medicine, microbiome and animal genetics markets.

OSUR Intrinsic Value
4.07 USD
Undervaluation 5%
Intrinsic Value
Price

See Also

What is OraSure Technologies Inc's Total Liabilities?
Total Liabilities
38.5m USD

Based on the financial report for Sep 30, 2024, OraSure Technologies Inc's Total Liabilities amounts to 38.5m USD.

What is OraSure Technologies Inc's Total Liabilities growth rate?
Total Liabilities CAGR 10Y
3%

Over the last year, the Total Liabilities growth was -28%. The average annual Total Liabilities growth rates for OraSure Technologies Inc have been -17% over the past three years , and 3% over the past ten years .

Back to Top